Category: 3235-67-4

In general, if the atoms that make up the ring contain heteroatoms, such rings become heterocycles, and organic compounds containing heterocycles are called heterocyclic compounds. An article called Piperidine scaffold as the novel P2-ligands in cyclopropyl-containing HIV-1 protease inhibitors: Structure-based design, synthesis, biological evaluation and docking study, published in 2020, which mentions a compound: 3235-67-4, Name is 1-Piperidineacetic Acid, Molecular C7H13NO2, SDS of cas: 3235-67-4.

A series of potent HIV-1 protease inhibitors, containing diverse piperidine analogs as the P2-ligands, 4-substituted phenylsulfonamides as the P2′-ligands and a hydrophobic cyclopropyl group as the P1′-ligand, were designed, synthesized and evaluated in this work. Among these twenty-four target compounds, many of them exhibited excellent activity against HIV-1 protease with half maximal inhibitory concentration (IC50) values below 20 nM. Particularly, compound I containing a (R)-piperidine-3-carboxamide as the P2-ligand and a 4-methoxylphenylsulfonamide as the P2′-ligand exhibited the most effective inhibitory activity with an IC50 value of 3.61 nM. More importantly, I exhibited activity with inhibition of 42% and 26% against wild-type and Darunavir (DRV)-resistant HIV-1 variants, resp. Addnl., the mol. docking of I with HIV-1 protease provided insight into the ligand-binding properties, which was of great value for further study.

From this literature《Piperidine scaffold as the novel P2-ligands in cyclopropyl-containing HIV-1 protease inhibitors: Structure-based design, synthesis, biological evaluation and docking study》,we know some information about this compound(3235-67-4)SDS of cas: 3235-67-4, but this is not all information, there are many literatures related to this compound(3235-67-4).

Reference:
Isoxazole – Wikipedia,
Isoxazole | C3H3NO – PubChem

In general, if the atoms that make up the ring contain heteroatoms, such rings become heterocycles, and organic compounds containing heterocycles are called heterocyclic compounds. An article called Acute toxicity and depressive effect on spontaneous motor activity of piperidine N-derivatives in mice, published in 1979-12-25, which mentions a compound: 3235-67-4, Name is 1-Piperidineacetic Acid, Molecular C7H13NO2, Product Details of 3235-67-4.

The acute toxicity and depressive effect on spontaneous motor activity of the title compounds I (R = CH2CO2H, CH2CH2OH, etc.) were examined using mice untreated and pretreated with phenobarbital and SKF-525A. The acute toxicity of I decreased and its depressive effect increased following enzyme induction, whereas following enzyme inhibition the opposite occurred. Structure-activity relations are discussed.

From this literature《Acute toxicity and depressive effect on spontaneous motor activity of piperidine N-derivatives in mice》,we know some information about this compound(3235-67-4)Product Details of 3235-67-4, but this is not all information, there are many literatures related to this compound(3235-67-4).

Reference:
Isoxazole – Wikipedia,
Isoxazole | C3H3NO – PubChem

Safety of 1-Piperidineacetic Acid. The fused heterocycle is formed by combining a benzene ring with a single heterocycle, or two or more single heterocycles. Compound: 1-Piperidineacetic Acid, is researched, Molecular C7H13NO2, CAS is 3235-67-4, about Discovery of N-((1-(4-(3-(3-((6,7-Dimethoxyquinolin-3-yl)oxy)phenyl)ureido)-2-(trifluoromethyl)phenyl)piperidin-4-yl)methyl)propionamide (CHMFL-KIT-8140) as a Highly Potent Type II Inhibitor Capable of Inhibiting the T670I “”Gatekeeper”” Mutant of cKIT Kinase. Author is Li, Binhua; Wang, Aoli; Liu, Juan; Qi, Ziping; Liu, Xiaochuan; Yu, Kailin; Wu, Hong; Chen, Cheng; Hu, Chen; Wang, Wenchao; Wu, Jiaxin; Hu, Zhenquan; Ye, Ling; Zou, Fengming; Liu, Feiyang; Wang, Beilei; Wang, Li; Ren, Tao; Zhang, Shaojuan; Bai, Mingfeng; Zhang, Shanchun; Liu, Jing; Liu, Qingsong.

CKIT kinase inhibitors, e.g., imatinib could induce drug-acquired mutations such as cKIT T670I that rendered drug resistance after chronic treatment. Through a type II kinase inhibitor design approach the authors discovered a highly potent type II cKIT kinase inhibitor compound 35 (CHMFL-KIT-8140), which potently inhibited both cKIT wt (IC50: 33 nM) and cKIT gatekeeper T670I mutant (IC50: 99 nM). Compound 35 displayed strong anti-proliferative effect against GISTs cancer cell lines GIST-T1 (cKIT wt, GI50: 4 nM) and GIST-5R (cKIT T670I, GI50: 26 nM). In the cellular context it strongly inhibited c-KIT mediated signaling pathways and induced apoptosis. In the BaF3-TEL-cKIT-T670I isogenic cell inoculated xenograft mouse model, 35 exhibited dose dependent tumor growth suppression efficacy and 100 mg/kg dosage provided 47.7% tumor growth inhibition (TGI) without obvious toxicity. The authors believe compound 35 would be a good pharmacol. tool for exploration of the cKIT-T670I mutant mediated pathol. in GISTs.

From this literature《Discovery of N-((1-(4-(3-(3-((6,7-Dimethoxyquinolin-3-yl)oxy)phenyl)ureido)-2-(trifluoromethyl)phenyl)piperidin-4-yl)methyl)propionamide (CHMFL-KIT-8140) as a Highly Potent Type II Inhibitor Capable of Inhibiting the T670I “”Gatekeeper”” Mutant of cKIT Kinase》,we know some information about this compound(3235-67-4)Safety of 1-Piperidineacetic Acid, but this is not all information, there are many literatures related to this compound(3235-67-4).

Reference:
Isoxazole – Wikipedia,
Isoxazole | C3H3NO – PubChem

So far, in addition to halogen atoms, other non-metallic atoms can become part of the aromatic heterocycle, and the target ring system is still aromatic.Cole, Kevin P.; Ryan, Sarah J.; McClary Groh, Jennifer; Miller, Richard D. researched the compound: 1-Piperidineacetic Acid( cas:3235-67-4 ).Related Products of 3235-67-4.They published the article 《Reagent-free continuous thermal tert-butyl ester deprotection》 about this compound( cas:3235-67-4 ) in Bioorganic & Medicinal Chemistry. Keywords: amino acid continuous plug flow reactor thermal BOC deprotection; continuous plug flow reactor thermal BOC deprotection; Continuous processing; Flow chemistry; Plug flow reactor; Thermolysis; tert-Butyl ester deprotection. We’ll tell you more about this compound (cas:3235-67-4).

Continuous processing enables the use of non-standard reaction conditions such as high temperatures and pressures while in the liquid phase. This expands the chemist’s toolbox and can enable previously unthinkable chem. to proceed with ease. For a series of amphoteric amino acid derivatives, we have demonstrated the ability to hydrolyze the tert-Bu ester functionality in protic solvent systems. Using a continuous plug flow reactor at 120-240 °C and 15-40 min reaction times, no pH modification or addnl. reagents are needed to achieve the desired transformation. The method was then expanded to encompass a variety of more challenging substrates to test selectivity and racemization potential. The acid products were generally isolated as crystalline solids by simple solvent exchange after the deprotection reaction in good to high yield and purity.

From this literature《Reagent-free continuous thermal tert-butyl ester deprotection》,we know some information about this compound(3235-67-4)Related Products of 3235-67-4, but this is not all information, there are many literatures related to this compound(3235-67-4).

Reference:
Isoxazole – Wikipedia,
Isoxazole | C3H3NO – PubChem

Recommanded Product: 3235-67-4. Aromatic compounds can be divided into two categories: single heterocycles and fused heterocycles. Compound: 1-Piperidineacetic Acid, is researched, Molecular C7H13NO2, CAS is 3235-67-4, about On the cleavage of N-C linkage of piperidine N-derivatives by mouse and rat liver enzyme system. Author is Kimura, Katsuhiko; Nagaoka, Masao; Nakazawa, Shuichi; Ohgiya, Shozaburo.

The cleavage of the N-C bond of piperidine derivatives by the 9000 × g supernatant of rat liver was more readily carried out than that by the supernatant of mouse liver. The cleavage of N-Et derivatives such as N-methylpiperidine (I) [626-67-5] and N-ethylpiperidine [766-09-6] was not readily carried out by these supernatants, whereas that of the Mannich bases was done readily. The addition of phenobarbital accelerated N-C bond cleavage, but 3-methylcholanthrene was without effect. Pretreatment of the animals with SKF-525A inhibited the cleavage.

From this literature《On the cleavage of N-C linkage of piperidine N-derivatives by mouse and rat liver enzyme system》,we know some information about this compound(3235-67-4)Recommanded Product: 3235-67-4, but this is not all information, there are many literatures related to this compound(3235-67-4).

Reference:
Isoxazole – Wikipedia,
Isoxazole | C3H3NO – PubChem

Reference of 1-Piperidineacetic Acid. The mechanism of aromatic electrophilic substitution of aromatic heterocycles is consistent with that of benzene. Compound: 1-Piperidineacetic Acid, is researched, Molecular C7H13NO2, CAS is 3235-67-4, about Piperidine scaffold as the novel P2-ligands in cyclopropyl-containing HIV-1 protease inhibitors: Structure-based design, synthesis, biological evaluation and docking study. Author is Zhou, Huiyu; Zhu, Mei; Ma, Ling; Zhou, Jinming; Dong, Biao; Zhang, Guoning; Cen, Shan; Wang, Yucheng; Wang, Juxian.

A series of potent HIV-1 protease inhibitors, containing diverse piperidine analogs as the P2-ligands, 4-substituted phenylsulfonamides as the P2′-ligands and a hydrophobic cyclopropyl group as the P1′-ligand, were designed, synthesized and evaluated in this work. Among these twenty-four target compounds, many of them exhibited excellent activity against HIV-1 protease with half maximal inhibitory concentration (IC50) values below 20 nM. Particularly, compound I containing a (R)-piperidine-3-carboxamide as the P2-ligand and a 4-methoxylphenylsulfonamide as the P2′-ligand exhibited the most effective inhibitory activity with an IC50 value of 3.61 nM. More importantly, I exhibited activity with inhibition of 42% and 26% against wild-type and Darunavir (DRV)-resistant HIV-1 variants, resp. Addnl., the mol. docking of I with HIV-1 protease provided insight into the ligand-binding properties, which was of great value for further study.

From this literature《Piperidine scaffold as the novel P2-ligands in cyclopropyl-containing HIV-1 protease inhibitors: Structure-based design, synthesis, biological evaluation and docking study》,we know some information about this compound(3235-67-4)Reference of 1-Piperidineacetic Acid, but this is not all information, there are many literatures related to this compound(3235-67-4).

Reference:
Isoxazole – Wikipedia,
Isoxazole | C3H3NO – PubChem

Yang, Yang; Zhou, Yuanzheng; Tao, Lei; Yang, Tao; Zhao, Yinglan; Luo, Youfu published the article 《Structure-activity relationship study of DEL-22379: ERK dimerization inhibitors with increased safety》. Keywords: lung liver cancer DEL22379 anticancer agent ERK signaling; Anti-cancer activity; ERK dimerization inhibitor; Indolin-2-one; Structure–activity relationship; Synthesis.They researched the compound: 1-Piperidineacetic Acid( cas:3235-67-4 ).Name: 1-Piperidineacetic Acid. Aromatic heterocyclic compounds can be divided into two categories: single heterocyclic and fused heterocyclic. In addition, there is a lot of other information about this compound (cas:3235-67-4) here.

Abstract: Aberrant activation of ERK signaling pathway usually leads to oncogenesis, and small mol. agents targeting this pathway are impeded by the emergence of drug resistance due to reactivation of ERK signaling. Compound DEL-22379 has been reported to inhibit ERK dimerization which was unaffected by drug-resistant mechanism reactivating the ERK signaling. Here, we discussed a structure-activity relationship study of DEL-22379. Forty-seven analogs were designed and synthesized. Each synthesized compound was biol. evaluated for their inhibitory rates on several tumor cell lines and compounds with high inhibitory rates were further evaluated for IC50 values. The structure-activity relationship of idolin-2-one scaffold and the impact of Z/E configuration on potency were discussed. Potential safety of two synthesized analogs was investigated and in silico docking study of five compounds was performed to understand the structural basis of ERK dimerization inhibition. Graphic abstract: [graphic not available: see fulltext].

From this literature《Structure-activity relationship study of DEL-22379: ERK dimerization inhibitors with increased safety》,we know some information about this compound(3235-67-4)Name: 1-Piperidineacetic Acid, but this is not all information, there are many literatures related to this compound(3235-67-4).

Reference:
Isoxazole – Wikipedia,
Isoxazole | C3H3NO – PubChem

The reaction of an aromatic heterocycle with a proton is called a protonation. One of articles about this theory is 《The stability of metal complexes of 1,4-piperazinediacetic acid》. Authors are Irving, H.; Pettit, L. D..The article about the compound:1-Piperidineacetic Acidcas:3235-67-4,SMILESS:OC(=O)CN1CCCCC1).Application of 3235-67-4. Through the article, more information about this compound (cas:3235-67-4) is conveyed.

1,4-Piperazinediacetic acid has been prepd and its acid dissociation constants have been measured at 20° and μ = 0.1M KCl. Values for the stability constants of its complexes with Mg, Ca, Sr, Ba, Ni, Cu(II), and Zn have been measured and are compared with corresponding data for 1-piperidine-acetic acid and other ligands of related structure. It is concluded that chelation involving both N atoms of the piperazine derivative does not occur with small ions.

From this literature《The stability of metal complexes of 1,4-piperazinediacetic acid》,we know some information about this compound(3235-67-4)Application of 3235-67-4, but this is not all information, there are many literatures related to this compound(3235-67-4).

Reference:
Isoxazole – Wikipedia,
Isoxazole | C3H3NO – PubChem

The reaction of an aromatic heterocycle with a proton is called a protonation. One of articles about this theory is 《Synthesis of spasmolytic substances. VII. Synthesis of some α-alkyl-α-piperidinoacetic acid esters》. Authors are Klosa, Josef.The article about the compound:1-Piperidineacetic Acidcas:3235-67-4,SMILESS:OC(=O)CN1CCCCC1).Electric Literature of C7H13NO2. Through the article, more information about this compound (cas:3235-67-4) is conveyed.

Since it had been shown that the α-cyclohexyl-α-piperidinoacetic acid esters have stronger analgetic action than the corresponding α-phenyl compounds, α-isobutyl compounds were prepared and tested. All compounds prepared showed spasmolytic but no analgetic action. α-Phenyl-α-isobutylacetonitrile (I), b. 94-100°, was prepared in 43-g. yield by adding 65 g. Ph(CH2CN drop by drop over a period of 90-120 min. to a well-stirred mixture of 30 g. finely powd. NaNH2 and 80 ml. absolute C6H6 at 30-40° (temperature critical), cooling to 10°, adding 83 g. iso-BuBr drop by drop over 1-2 hrs. at 10-20°, warming 1 hr. at 50-70° and 3 hrs. at 60-70°; cooling, letting stand overnight, adding 200 ml. 25% EtOH, shaking, separating the layers, extracting the aqueous layer with C6H6, washing the combined organic layers with HCl and H2O, drying, evaporating in vacuo, and fractionating the residue. α-Phenyl-α-isobutyl-α-(β-piperidinoethyl)acetonitrile-HCl (II), m. 194-6° (decomposition), was prepared by treating 14 g. I with 8 g. NaNH2 in 120 ml. absolute C6H6 1 hr. at 30°, then 1 hr. at 40° and finally 20 min. at 50-60°, adding finely powd. and dried β-piperidinoethyl chloride, increasing the temperature to 60-70° in 1 hr. and keeping it at 60-70° 2 hrs., boiling 90 min., letting stand overnight, adding 120 ml. H2O, shaking, separating the layers, and extracting the crude II with 2N HCl from the C6H6 solution α-Phenyl-α-isobutyl-α-(β-dimethylaminoethyl)acetonitrile-HCl (III), m. 242-4°, and α-phenyl-α-isobutyl-α-(βdiethylaminoethyl)acetonitrile-HCl, m. 133-5° were prepared like II. The esters of the acids derived from nitriles II, III, and IV (V) were prepared by passing HCl through a solution of 3 g. nitrile in 40-60 ml. of the appropriate alc. 3 hrs. at room temperature, heating on the steam bath to 50-80° while continuing HCl input, letting stand overnight in a closed flask, evaporating excess alc. in vacuo, cooling the residue, making alk. with aqueous alkali, extracting with C6H6, and working up. The following V were prepared (nitrile used, esterifying alc.): II, MeOH; II, EtOH; II, iso-PrOH; III, MeOH; III, EtOH; III, iso-PrOH; IV, MeOH; IV, EtOH; IV, iso-PrOH. No b.ps. are given.

If you want to learn more about this compound(1-Piperidineacetic Acid)Electric Literature of C7H13NO2, you may wish to communicate with the author of the article,or consult the relevant literature related to this compound(3235-67-4).

Reference:
Isoxazole – Wikipedia,
Isoxazole | C3H3NO – PubChem

The three-dimensional configuration of the ester heterocycle is basically the same as that of the carbocycle. Compound: 1-Piperidineacetic Acid(SMILESS: OC(=O)CN1CCCCC1,cas:3235-67-4) is researched.Category: dioxole. The article 《Non-NAD-like PARP-1 inhibitors in prostate cancer treatment》 in relation to this compound, is published in Biochemical Pharmacology (Amsterdam, Netherlands). Let’s take a look at the latest research on this compound (cas:3235-67-4).

In our previous studies of the mol. mechanisms of poly(ADP-ribose) polymerase 1 (PARP-1)-mediated transcriptional regulation we identified a novel class of PARP-1 inhibitors targeting the histone-dependent route of PARP-1 activation. Because histone-dependent activation is unique to PARP-1, non-NAD-like PARP-1 inhibitors have the potential to bypass the off-target effects of classical NAD-dependent PARP-1 inhibitors, such as olaparib, veliparib, and rucaparib. Furthermore, our recently published studies demonstrate that, compared to NAD-like PARP-1 inhibitors that are used clin., the non-NAD-like PARP-1 inhibitor 5F02 exhibited superior antitumor activity in cell and animal models of human prostate cancer (PC). In this study, we further evaluated the antitumor activity of 5F02 and several of its novel analogs against PC cells. In contrast to NAD-like PARP-1 inhibitors, non-NAD-like PARP-1 inhibitors demonstrated efficacy against androgen-dependent and -independent routes of androgen receptor signaling activation. Our experiments reveal that methylation of the quaternary ammonium salt and the presence of esters were critical for the antitumor activity of 5F02 against PC cells. In addition, we examined the role of a related regulatory protein of PARP-1, called Poly(ADP-ribose) glycohydrolase (PARG), in prostate carcinogenesis. Our study reveals that PARG expression is severely disrupted in PC cells, which is associated with decreased integrity and localization of Cajal bodies (CB). Overall, the results of our study strengthen the justification for using non-NAD-like PARP-1 inhibitors as a novel therapeutic strategy for the treatment of advanced prostate cancer.

If you want to learn more about this compound(1-Piperidineacetic Acid)HPLC of Formula: 3235-67-4, you may wish to communicate with the author of the article,or consult the relevant literature related to this compound(3235-67-4).

Reference:
Isoxazole – Wikipedia,
Isoxazole | C3H3NO – PubChem